Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Medicenna Therapeutics Corp. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 3
- −23 vs. Q3 2023
- Shares held
- 129.0K
- −9.48M (−98.7%) vs. Q3 2023
- Total value
- $40.9K
- −$2.41M (−98.3%) vs. Q3 2023
- New holders
- 1
- 0 more added
- Sold out
- 24
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDNAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $200.4K |
| Q3 2024 | 1 | $175.0K |
| Q2 2024 | 1 | $145.0K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $40.9K |
| Q3 2023 | 26 | $2.45M |
| Q2 2023 | 28 | $4.75M |
| Q1 2023 | 28 | $6.25M |
| Q4 2022 | 28 | $4.75M |
| Q3 2022 | 29 | $9.67M |
| Q2 2022 | 19 | $5.41M |
| Q1 2022 | 20 | $5.47M |
| Q4 2021 | 23 | $7.42M |
| Q3 2021 | 25 | $8.66M |
| Q2 2021 | 26 | $15.4M |
| Q1 2021 | 31 | $22.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Medicenna Therapeutics Corp.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rathbone Brothers plc | 105,663 | $33.8K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 12,915 | $3.94K | 0.00% | +12,915 | New |
| Raymond James & Associates | 10,400 | $3.17K | 0.00% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −4,339,983−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −1,088,938−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −780,564−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −634,550−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −555,392−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −173,945−100.0% | Sold out |
| AWM Investment Company, Inc. | 0 | $0 | 0.00% | −1,330,000−100.0% | Sold out |
| Letko, Brosseau & Associates Inc | 0 | $0 | 0.00% | −120,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −85,113−100.0% | Sold out |
| McKinley Carter Wealth Services, Inc. | 0 | $0 | 0.00% | −79,259−100.0% | Sold out |
| Tocqueville Asset Management L.P. | 0 | $0 | 0.00% | −79,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −38,092−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −34,144−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −27,626−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −24,988−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Great Valley Advisor Group, Inc. | 0 | $0 | 0.00% | −19,500−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,605−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,086−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,800−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −1,677−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −715−100.0% | Sold out |